Morpholine, 4-dodecyl-,4-oxide

Suppliers

Names

[ CAS No. ]:
2530-46-3

[ Name ]:
Morpholine, 4-dodecyl-,4-oxide

[Synonym ]:
4-Dodecylmorpholin-N-oxid
N-Dodecyl-morpholinoxid
N-Laurylmorpholine oxide
4-Dodecylmorpholine-N-oxide
N-Dodecylmorpholine N-oxide
Morpholine,4-dodecyl-,4-oxide
4-dodecylmorpholine 4-oxide

Chemical & Physical Properties

[ Molecular Formula ]:
C16H33NO2

[ Molecular Weight ]:
271.43900

[ Exact Mass ]:
271.25100

[ PSA ]:
38.66000

[ LogP ]:
4.21090

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QE3410000
CHEMICAL NAME :
Morpholine, 4-dodecyl-, 4-oxide
CAS REGISTRY NUMBER :
2530-46-3
LAST UPDATED :
199701
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C16-H33-N-O2
MOLECULAR WEIGHT :
271.50

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1880 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PESTD5 Proceedings of the European Society of Toxicology. (Amsterdam, Netherlands) V.16-18, 1975-77. Discontinued. Volume(issue)/page/year: 16,236,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
110 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PESTD5 Proceedings of the European Society of Toxicology. (Amsterdam, Netherlands) V.16-18, 1975-77. Discontinued. Volume(issue)/page/year: 16,236,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
68 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PESTD5 Proceedings of the European Society of Toxicology. (Amsterdam, Netherlands) V.16-18, 1975-77. Discontinued. Volume(issue)/page/year: 16,236,1975

Related Compounds

  • Morpholine,4-pentadecyl-, 4-oxide
  • Morpholine,4-heptyl-, 4-oxide
  • Morpholine,4-hexadecyl-, 4-oxide
  • Morpholine, 4-ethyl-,4-oxide
  • Morpholine, 4-decyl-,4-oxide
  • Morpholine,4-tetradecyl-, 4-oxide
  • N-(2-(4-(isopropylamino)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-4-phenylbutanamide
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • Ethyl 4-(2-ethylbutanamido)-1-(4-fluorophenyl)-6-oxo-1,6-dihydropyridazine-3-carboxylate
  • 3,3-Bis(2-methyl-1H-indol-3-yl)-1(3H)-isobenzofuranone
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 2-((3-chloro-4-fluorophenyl)amino)-2-oxoethyl 4-(1,1-dioxido-2H-benzo[e][1,2,4]thiadiazin-3-yl)butanoate